174 related articles for article (PubMed ID: 23604529)
1. STAT3 acetylation-induced promoter methylation is associated with downregulation of the ARHI tumor-suppressor gene in ovarian cancer.
Li J; Cui G; Sun L; Wang SJ; Li YL; Meng YG; Guan Z; Fan WS; Li LA; Yang YZ; You YQ; Fu XY; Yan ZF; Huang K
Oncol Rep; 2013 Jul; 30(1):165-70. PubMed ID: 23604529
[TBL] [Abstract][Full Text] [Related]
2. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
3. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
4. A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells.
Nishimoto A; Yu Y; Lu Z; Mao X; Ren Z; Watowich SS; Mills GB; Liao WS; Chen X; Bast RC; Luo RZ
Cancer Res; 2005 Aug; 65(15):6701-10. PubMed ID: 16061651
[TBL] [Abstract][Full Text] [Related]
5. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
6. Multiple histone deacetylases repress tumor suppressor gene ARHI in breast cancer.
Feng W; Lu Z; Luo RZ; Zhang X; Seto E; Liao WS; Yu Y
Int J Cancer; 2007 Apr; 120(8):1664-8. PubMed ID: 17230502
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of ARHI in breast and ovarian cancer cells.
Yu Y; Fujii S; Yuan J; Luo RZ; Wang L; Bao J; Kadota M; Oshimura M; Dent SR; Issa JP; Bast RC
Ann N Y Acad Sci; 2003 Mar; 983():268-77. PubMed ID: 12724231
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer.
Lu Z; Luo RZ; Peng H; Rosen DG; Atkinson EN; Warneke C; Huang M; Nishmoto A; Liu J; Liao WS; Yu Y; Bast RC
Clin Cancer Res; 2006 Apr; 12(8):2404-13. PubMed ID: 16638845
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
10. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.
Rosen DG; Wang L; Jain AN; Lu KH; Luo RZ; Yu Y; Liu J; Bast RC
Clin Cancer Res; 2004 Oct; 10(19):6559-66. PubMed ID: 15475444
[TBL] [Abstract][Full Text] [Related]
11. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
[TBL] [Abstract][Full Text] [Related]
12. Correlation of ARHI upregulation with growth suppression and STAT3 inactivation in resveratrol-treated ovarian cancer cells.
Zhong LX; Nie JH; Liu J; Lin LZ
Cancer Biomark; 2018; 21(4):787-795. PubMed ID: 29504523
[TBL] [Abstract][Full Text] [Related]
13. The expression of ARHI in pT2a and pT2b stage gastric cancer and its clinical significance.
Wang W; Bu XM; Wang J; Zhang N; Zhao CH
Oncol Rep; 2012 Jun; 27(6):1953-9. PubMed ID: 22427032
[TBL] [Abstract][Full Text] [Related]
14. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R
Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
[TBL] [Abstract][Full Text] [Related]
15. The Role of Methylation in the CpG Island of the ARHI Promoter Region in Cancers.
Liu X; Zhang T; Li Y; Zhang Y; Zhang H; Wang X; Li L
Adv Exp Med Biol; 2020; 1255():123-132. PubMed ID: 32949395
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications.
Zhang C; Li H; Wang Y; Liu W; Zhang Q; Zhang T; Zhang X; Han B; Zhou G
J Hepatol; 2010 Nov; 53(5):889-95. PubMed ID: 20675009
[TBL] [Abstract][Full Text] [Related]
17. Biochemistry and biology of ARHI (DIRAS3), an imprinted tumor suppressor gene whose expression is lost in ovarian and breast cancers.
Yu Y; Luo R; Lu Z; Wei Feng W; Badgwell D; Issa JP; Rosen DG; Liu J; Bast RC
Methods Enzymol; 2006; 407():455-68. PubMed ID: 16757345
[TBL] [Abstract][Full Text] [Related]
18. Aplasia ras homolog member I is downregulated in gastric cancer and silencing its expression promotes cell growth in vitro.
Tang HL; Hu YQ; Qin XP; Jazag A; Yang H; Yang YX; Yang XN; Liu JJ; Chen JM; Guleng B; Ren JL
J Gastroenterol Hepatol; 2012 Aug; 27(8):1395-404. PubMed ID: 22497484
[TBL] [Abstract][Full Text] [Related]
19. Reactivation of the silenced and imprinted alleles of ARHI is associated with increased histone H3 acetylation and decreased histone H3 lysine 9 methylation.
Fujii S; Luo RZ; Yuan J; Kadota M; Oshimura M; Dent SR; Kondo Y; Issa JP; Bast RC; Yu Y
Hum Mol Genet; 2003 Aug; 12(15):1791-800. PubMed ID: 12874100
[TBL] [Abstract][Full Text] [Related]
20. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
Magdinier F; Wolffe AP
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4990-5. PubMed ID: 11309512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]